Benign prostate hyperplasia (BPH) is a disease that affects over 15 million males in the U.S. and is characterized by smooth muscle proliferation in the prostate that can lead to lower urinary tract symptoms (LUTS), including urinary frequency, urgency (particularly at night) and incontinence which can have a significant impact on quality of life. Management of BPH has historically involved medications, lifestyle modifications, and regulating dietary and fluid intake and output.
Those patients who are refractory to these treatments have been referred for transurethral resection of the prostate (TURP), which is currently the gold standard definitive treatment for BPH. However, this procedure does come with significant risks including bleeding and nerve damage potentially leading to impotence. As a result, alternative options have been explored, although a number of these new techniques…
